Compound ID | 3004
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Escherichia coli and Klebsiella pneumoniae; LpxH inhibitor |
| Description: | Synthetic compound; derived from JEDI-1444 to improve drug-like properties; cytotoxicity (IC50) to HepG2 cells at 55 uM |
| Institute where first reported: | Department of Medical Biochemistry and Microbiology, BMC, Uppsala University, Uppsala SE-75123, Sweden |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://www.pnas.org/doi/10.1073/pnas.2317274121 |
| Patent: | WO2022/220725 (PCT/SE2022/050360) |